HIPK2 modification code for cell death and survival

References

• Arai S, Matsushita A, Du K, Yagi K, Okazaki Y, Kurokawa R. Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9. FEBS Lett 2007; 581:5649-57; PMID:18022393; http://dx.doi.org/10.1016/j.febslet.2007.11.022
   PubMed Web of Science ®Google Scholar
• He Q, Shi J, Sun H, An J, Huang Y, Sheikh MS. Characterization of human homeodomain-interacting protein kinase 4 (HIPK4) as a unique member of the HIPK family. Mol Cell Pharmacol 2010; 2:61-8; PMID:20508833
   PubMedGoogle Scholar
• Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 1998; 273:25875-9; PMID:9748262; http://dx.doi.org/10.1074/jbc.273.40.25875
   PubMed Web of Science ®Google Scholar
• Wiggins AK, Wei G, Doxakis E, Wong C, Tang AA, Zang K, Luo EJ, Neve RL, Reichardt LF, Huang EJ. Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival. J Cell Biol 2004; 167:257-67; PMID:15492043; http://dx.doi.org/10.1083/jcb.200406131
   PubMed Web of Science ®Google Scholar
• Kondo S, Lu Y, Debbas M, Lin AW, Sarosi I, Itie A, Wakeham A, Tuan J, Saris C, Elliott G, et al. Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1). Proc Natl Acad Sci U S A 2003; 100:5431-6; PMID:12702766; http://dx.doi.org/10.1073/pnas.0530308100
   PubMed Web of Science ®Google Scholar
• Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML, Koseki H, Kitabayashi I. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J 2006; 25:3955-65; PMID:16917507; http://dx.doi.org/10.1038/sj.emboj.7601273
   PubMed Web of Science ®Google Scholar
• Isono K, Nemoto K, Li Y, Takada Y, Suzuki R, Katsuki M, Nakagawara A, Koseki H. Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Mol Cell Biol 2006; 26:2758-71; PMID:16537918; http://dx.doi.org/10.1128/MCB.26.7.2758-2771.2006
   PubMed Web of Science ®Google Scholar
• Shang Y, Doan CN, Arnold TD, Lee S, Tang AA, Reichardt LF, Huang EJ. Transcriptional corepressors HIPK1 and HIPK2 control angiogenesis via TGF-beta-TAK1-dependent mechanism. PLoS Biol 2013; 11:e1001527; PMID:23565059; http://dx.doi.org/10.1371/journal.pbio.1001527
   PubMed Web of Science ®Google Scholar
• Chalazonitis A, Tang AA, Shang Y, Pham TD, Hsieh I, Setlik W, Gershon MD, Huang EJ. Homeodomain interacting protein kinase 2 regulates postnatal development of enteric dopaminergic neurons and glia via BMP signaling. J Neurosci: Official J Soc Neurosci 2011; 31:13746-57; PMID:21957238; http://dx.doi.org/10.1523/JNEUROSCI.1078-11.2011
   PubMed Web of Science ®Google Scholar
• Hattangadi SM, Burke KA, Lodish HF. Homeodomain-interacting protein kinase 2 plays an important role in normal terminal erythroid differentiation. Blood 2010; 115:4853-61; PMID:20231426; http://dx.doi.org/10.1182/blood-2009-07-235093
   PubMed Web of Science ®Google Scholar
• de la Vega L, Hornung J, Kremmer E, Milanovic M, Schmitz ML. Homeodomain-interacting protein kinase 2-dependent repression of myogenic differentiation is relieved by its caspase-mediated cleavage. Nucleic Acids Res 2013; 41:5731-45; PMID:23620283; http://dx.doi.org/10.1093/nar/gkt262
   PubMed Web of Science ®Google Scholar
• Ciarapica R, Methot L, Tang Y, Lo R, Dali R, Buscarlet M, Locatelli F, del Sal G, Rota R, Stifani S. Prolyl isomerase Pin1 and protein kinase HIPK2 cooperate to promote cortical neurogenesis by suppressing GrouchoTLE: Hes1-mediated inhibition of neuronal differentiation. Cell Death Differ 2014; 21:321-32; PMID:24270405; http://dx.doi.org/10.1038/cdd.2013.160
   PubMed Web of Science ®Google Scholar
• Sjolund J, Pelorosso FG, Quigley DA, DelRosario R, Balmain A. Identification of Hipk2 as an essential regulator of white fat development. Proc Natl Acad Sci U S A 2014; 111:7373-8; PMID:24785298; http://dx.doi.org/10.1073/pnas.1322275111
   PubMed Web of Science ®Google Scholar
• Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W, Will H, Schmitz ML. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 2002; 4:1-10; PMID:11740489; http://dx.doi.org/10.1038/ncb715
   PubMed Web of Science ®Google Scholar
• D’Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, Gostissa M, Coen S, Marchetti A, Del Sal G, et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002; 4:11-9; PMID:11780126; http://dx.doi.org/10.1038/ncb714
   PubMed Web of Science ®Google Scholar
• Kanei-Ishii C, Ninomiya-Tsuji J, Tanikawa J, Nomura T, Ishitani T, Kishida S, Kokura K, Kurahashi T, Ichikawa-Iwata E, Kim Y, et al. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev 2004; 18:816-29; PMID:15082531; http://dx.doi.org/10.1101/gad.1170604
   PubMed Web of Science ®Google Scholar
• Lee W, Andrews BC, Faust M, Walldorf U, Verheyen EM. Hipk is an essential protein that promotes Notch signal transduction in the Drosophila eye by inhibition of the global co-repressor Groucho. Dev Biol 2009; 325:263-72; PMID:19013449; http://dx.doi.org/10.1016/j.ydbio.2008.10.029
   PubMed Web of Science ®Google Scholar
• Jin Y, Ratnam K, Chuang PY, Fan Y, Zhong Y, Dai Y, Mazloom AR, Chen EY, D’Agati V, Xiong H, et al. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nat Med 2012; 18:580-8; PMID:22406746; http://dx.doi.org/10.1038/nm.2685
   PubMed Web of Science ®Google Scholar
• Swarup S, Verheyen EM. Drosophila homeodomain-interacting protein kinase inhibits the Skp1-Cul1-F-box E3 ligase complex to dually promote Wingless and Hedgehog signaling. Proc Natl Acad Sci U S A 2011; 108:9887-92; PMID:21628596; http://dx.doi.org/10.1073/pnas.1017548108
   PubMed Web of Science ®Google Scholar
• Poon CL, Zhang X, Lin JI, Manning SA, Harvey KF. Homeodomain-interacting protein kinase regulates Hippo pathway-dependent tissue growth. Curr Biol: CB 2012; 22:1587-94; PMID:22840515; http://dx.doi.org/10.1016/j.cub.2012.06.075
   PubMed Web of Science ®Google Scholar
• Chen J, Verheyen EM. Homeodomain-interacting protein kinase regulates Yorkie activity to promote tissue growth. Curr Biol: CB 2012; 22:1582-6; PMID:22840522; http://dx.doi.org/10.1016/j.cub.2012.06.074
   PubMed Web of Science ®Google Scholar
• Sombroek D, Hofmann TG. How cells switch HIPK2 on and off. Cell Death Differ 2009; 16:187-94; PMID:18974774; http://dx.doi.org/10.1038/cdd.2008.154
   PubMed Web of Science ®Google Scholar
• Calzado MA, Renner F, Roscic A, Schmitz ML. HIPK2: a versatile switchboard regulating the transcription machinery and cell death. Cell Cycle 2007; 6:139-43; PMID:17245128; http://dx.doi.org/10.4161/cc.6.2.3788
   PubMed Web of Science ®Google Scholar
• Puca R, Nardinocchi L, Givol D, D’Orazi G. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene 2010; 29:4378-87; PMID:20514025; http://dx.doi.org/10.1038/onc.2010.183
   PubMed Web of Science ®Google Scholar
• Choi DW, Seo YM, Kim EA, Sung KS, Ahn JW, Park SJ, Lee SR, Choi CY. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeatSOCS box protein WSB-1. J Biol Chem 2008; 283:4682-9; PMID:18093972; http://dx.doi.org/10.1074/jbc.M708873200
   PubMed Web of Science ®Google Scholar
• Bitomsky N, Conrad E, Moritz C, Polonio-Vallon T, Sombroek D, Schultheiss K, Glas C, Greiner V, Herbel C, Mantovani F, et al. Autophosphorylation and Pin1 binding coordinate DNA damage-induced HIPK2 activation and cell death. Proc Natl Acad Sci U S A 2013; 110:E4203-12; PMID:24145406; http://dx.doi.org/10.1073/pnas.1310001110
   PubMed Web of Science ®Google Scholar
• Saul VV, de la Vega L, Milanovic M, Kruger M, Braun T, Fritz-Wolf K, Becker K, Schmitz ML. HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop. J Mol Cell Biol 2013; 5:27-38; PMID:23000554; http://dx.doi.org/10.1093/jmcb/mjs053
   PubMed Web of Science ®Google Scholar
• Siepi F, Gatti V, Camerini S, Crescenzi M, Soddu S. HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation. Biochim Biophys Acta 2013; 1833:1443-53; PMID:23485397; http://dx.doi.org/10.1016/j.bbamcr.2013.02.018
   PubMed Web of Science ®Google Scholar
• Tong Y, Li QG, Xing TY, Zhang M, Zhang JJ, Xia Q. HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells. FEBS Lett 2013; 587:2530-5; PMID:23792163; http://dx.doi.org/10.1016/j.febslet.2013.06.017
   PubMed Web of Science ®Google Scholar
• Shima Y, Shima T, Chiba T, Irimura T, Pandolfi PP, Kitabayashi I. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol Cell Biol 2008; 28:7126-38; PMID:18809579; http://dx.doi.org/10.1128/MCB.00897-08
   PubMed Web of Science ®Google Scholar
• Möller A SH, Hofmann TG, Rueffer S, Klimczak E, Dröge W, Will H, Schmitz ML. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res 2003; 1:4310-4; PMID:12907596
   PubMed Web of Science ®Google Scholar
• Kim SY, Choi DW, Kim EA, Choi CY. Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1. Cancer Lett 2009; 279:177-84; PMID:19250734; http://dx.doi.org/10.1016/j.canlet.2009.01.036
   PubMed Web of Science ®Google Scholar
• Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J, Hofmann TG. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol 2008; 10:812-24; PMID:18536714; http://dx.doi.org/10.1038/ncb1743
   PubMed Web of Science ®Google Scholar
• Crone J, Glas C, Schultheiss K, Moehlenbrink J, Krieghoff-Henning E, Hofmann TG. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis. Cancer research 2011; 71:2350-9; PMID:21248071; http://dx.doi.org/10.1158/0008-5472.CAN-10-3486
   PubMed Web of Science ®Google Scholar
• D’Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007; 8:813-24; PMID:17848967; http://dx.doi.org/10.1038/nrm2256
   PubMed Web of Science ®Google Scholar
• Li Q, Lin S, Wang X, Lian G, Lu Z, Guo H, Ruan K, Wang Y, Ye Z, Han J, et al. Axin determines cell fate by controlling the p53 activation threshold after DNA damage. Nat Cell Biol 2009; 11:1128-34; PMID:19731416; http://dx.doi.org/10.1038/ncb1927
   PubMed Web of Science ®Google Scholar
• Rinaldo C, Moncada A, Gradi A, Ciuffini L, D’Eliseo D, Siepi F, Prodosmo A, Giorgi A, Pierantoni GM, Trapasso F, et al. HIPK2 controls cytokinesis and prevents tetraploidization by phosphorylating histone H2B at the midbody. Mol Cell 2012; 47:87-98; PMID:22658722
   PubMed Web of Science ®Google Scholar
• Iacovelli S, Ciuffini L, Lazzari C, Bracaglia G, Rinaldo C, Prodosmo A, Bartolazzi A, Sacchi A, Soddu S. HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage. Cell Proliferat 2009; 42:373-84; PMID:19438900; http://dx.doi.org/10.1111/j.1365-2184.2009.00601.x
   PubMed Web of Science ®Google Scholar
• Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell 2012; 47:497-510; PMID:22920291; http://dx.doi.org/10.1016/j.molcel.2012.07.029
   PubMed Web of Science ®Google Scholar
• Shreeram S, Demidov ON, Hee WK, Yamaguchi H, Onishi N, Kek C, Timofeev ON, Dudgeon C, Fornace AJ, Anderson CW, et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol Cell 2006; 23:757-64; PMID:16949371; http://dx.doi.org/10.1016/j.molcel.2006.07.010
   PubMed Web of Science ®Google Scholar
• Cha H, Lowe JM, Li H, Lee JS, Belova GI, Bulavin DV, Fornace AJ, Jr. Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response. Cancer Res 2010; 70:4112-22; PMID:20460517; http://dx.doi.org/10.1158/0008-5472.CAN-09-4244
   PubMed Web of Science ®Google Scholar
• Calzado MA, de la Vega L, Moller A, Bowtell DD, Schmitz ML. An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat Cell Biol 2009; 11:85-91; PMID:19043406; http://dx.doi.org/10.1038/ncb1816
   PubMed Web of Science ®Google Scholar
• Yamada D, Perez-Torrado R, Filion G, Caly M, Jammart B, Devignot V, Sasai N, Ravassard P, Mallet J, Sastre-Garau X, et al. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4. Oncogene 2009; 28:2535-44; PMID:19448668; http://dx.doi.org/10.1038/onc.2009.109
   PubMed Web of Science ®Google Scholar
• Choi CY, Kim YH, Kim YO, Park SJ, Kim EA, Riemenschneider W, Gajewski K, Schulz RA, Kim Y. Phosphorylation by the DHIPK2 protein kinase modulates the corepressor activity of Groucho. J Biol Chem 2005; 280:21427-36; PMID:15802274; http://dx.doi.org/10.1074/jbc.M500496200
   PubMed Web of Science ®Google Scholar
• Choi CY, Kim YH, Kwon HJ, Kim Y. The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription. J Biol Chem 1999; 274:33194-7; PMID:10559189; http://dx.doi.org/10.1074/jbc.274.47.33194
   PubMed Web of Science ®Google Scholar
• Nardinocchi L, Puca R, Sacchi A, D’Orazi G. HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA. Biochem Biophys Res Commun 2007; 361:249-55; PMID:17658469; http://dx.doi.org/10.1016/j.bbrc.2007.07.031
   PubMed Web of Science ®Google Scholar
• Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Ann Rev Pharmacol Toxicol 2012; 52:381-400; PMID:22017684; http://dx.doi.org/10.1146/annurev-pharmtox-010611-134537
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13:132-41; PMID:21258367; http://dx.doi.org/10.1038/ncb2152
   PubMed Web of Science ®Google Scholar
• Fiscella M, Zhang H, Fan S, Sakaguchi K, Shen S, Mercer WE, Vande Woude GF, O’Connor PM, Appella E. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A 1997; 94:6048-53; PMID:9177166; http://dx.doi.org/10.1073/pnas.94.12.6048
   PubMed Web of Science ®Google Scholar
• Rossi M, Demidov ON, Anderson CW, Appella E, Mazur SJ. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites. Nucleic Acids Research 2008; 36:7168-80; PMID:19015127; http://dx.doi.org/10.1093/nar/gkn888
   PubMed Web of Science ®Google Scholar
• Roscic A, Moller A, Calzado MA, Renner F, Wimmer VC, Gresko E, Ludi KS, Schmitz ML. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol Cell 2006; 24:77-89; PMID:17018294; http://dx.doi.org/10.1016/j.molcel.2006.08.004
   PubMed Web of Science ®Google Scholar
• Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F, Soddu S. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 2007; 25:739-50; PMID:17349959; http://dx.doi.org/10.1016/j.molcel.2007.02.008
   PubMed Web of Science ®Google Scholar
• Manfredi JJ. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev 2010; 24:1580-9; PMID:20679392
   PubMed Web of Science ®Google Scholar
• He Y, Lian G, Lin S, Ye Z, Li Q. MDM2 inhibits axin-induced p53 activation independently of its E3 ligase activity. PloS One 2013; 8:e67529; PMID:23826318; http://dx.doi.org/10.1371/journal.pone.0067529
   PubMed Web of Science ®Google Scholar
• Rinaldo C, Prodosmo A, Siepi F, Moncada A, Sacchi A, Selivanova G, Soddu S. HIPK2 regulation by MDM2 determines tumor cell response to the p53-reactivating drugs nutlin-3 and RITA. Cancer Res 2009; 69:6241-8; PMID:19638586; http://dx.doi.org/10.1158/0008-5472.CAN-09-0337
   PubMed Web of Science ®Google Scholar
• Choi DW, Na W, Kabir MH, Yi E, Kwon S, Yeom J, Ahn JW, Choi HH, Lee Y, Seo KW, et al. WIP1, a homeostatic regulator of the DNA damage response, is targeted by HIPK2 for phosphorylation and degradation. Mol Cell 2013; 51:374-85; PMID:23871434; http://dx.doi.org/10.1016/j.molcel.2013.06.010
   PubMed Web of Science ®Google Scholar
• Polonio-Vallon T, Kirkpatrick J, Krijgsveld J, Hofmann TG. Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization. Cell Cycle 2014; 13:115-25; PMID:24196445; http://dx.doi.org/10.4161/cc.26857
   PubMed Web of Science ®Google Scholar
• Moller A, Sirma H, Hofmann TG, Rueffer S, Klimczak E, Droge W, Will H, Schmitz ML. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res 2003; 63:4310-4; PMID:12907596
   PubMed Web of Science ®Google Scholar
• Li Q, Wang X, Wu X, Rui Y, Liu W, Wang J, Wang X, Liou YC, Ye Z, Lin SC. Daxx cooperates with the AxinHIPK2p53 complex to induce cell death. Cancer Res 2007; 67:66-74; PMID:17210684; http://dx.doi.org/10.1158/0008-5472.CAN-06-1671
   PubMed Web of Science ®Google Scholar
• Gresko E, Ritterhoff S, Sevilla-Perez J, Roscic A, Frobius K, Kotevic I, Vichalkovski A, Hess D, Hemmings BA, Schmitz ML. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage. Oncogene 2009; 28:698-708; PMID:19015637; http://dx.doi.org/10.1038/onc.2008.420
   PubMed Web of Science ®Google Scholar
• Dauth I, Kruger J, Hofmann TG. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Cancer Res 2007; 67:2274-9; PMID:17332358; http://dx.doi.org/10.1158/0008-5472.CAN-06-2884
   PubMed Web of Science ®Google Scholar
• Di Stefano V, Blandino G, Sacchi A, Soddu S, D’Orazi G. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function. Oncogene 2004; 23:5185-92; PMID:15122315; http://dx.doi.org/10.1038/sj.onc.1207656
   PubMed Web of Science ®Google Scholar
• Di Stefano V, Mattiussi M, Sacchi A, D’Orazi G. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations. FEBS Lett 2005; 579:5473-80; PMID:16212962; http://dx.doi.org/10.1016/j.febslet.2005.09.008
   PubMed Web of Science ®Google Scholar
• Zhang XP, Liu F, Wang W. Interplay between Mdm2 and HIPK2 in the DNA damage response. J Roy Soc, Interf Roy Soc 2014; 11; 20140319; PMID:24829283
   PubMedGoogle Scholar
• Dai C, Gu W. p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med 2010; 16:528-36; PMID:20932800; http://dx.doi.org/10.1016/j.molmed.2010.09.002
   PubMed Web of Science ®Google Scholar
• Puca R, Nardinocchi L, Sacchi A, Rechavi G, Givol D, D’Orazi G. HIPK2 modulates p53 activity towards pro-apoptotic transcription. Mol Cancer 2009; 8:85; PMID:19828042; http://dx.doi.org/10.1186/1476-4598-8-85
   PubMed Web of Science ®Google Scholar
• Di Stefano V, Soddu S, Sacchi A, D’Orazi G. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. Oncogene 2005; 24:5431-42; PMID:15897882; http://dx.doi.org/10.1038/sj.onc.1208717
   PubMed Web of Science ®Google Scholar
• Puca R, Nardinocchi L, Starace G, Rechavi G, Sacchi A, Givol D, D’Orazi G. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis. Free Radical Biol Med 2010; 48:1338-46; PMID:20171273; http://dx.doi.org/10.1016/j.freeradbiomed.2010.02.015
   PubMed Web of Science ®Google Scholar
• Grishina I, Debus K, Garcia-Limones C, Schneider C, Shresta A, Garcia C, Calzado MA, Schmitz ML. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation. Biochim Biophys Acta 2012; 1823:2287-96; PMID:23044042; http://dx.doi.org/10.1016/j.bbamcr.2012.09.011
   PubMed Web of Science ®Google Scholar
• Zhang Q, Nottke A, Goodman RH. Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis. Proc Natl Acad Sci U S A 2005; 102:2802-7; PMID:15708980; http://dx.doi.org/10.1073/pnas.0409373102
   PubMed Web of Science ®Google Scholar
• Chinnadurai G. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res 2009; 69:731-4; PMID:19155295; http://dx.doi.org/10.1158/0008-5472.CAN-08-3349
   PubMed Web of Science ®Google Scholar
• Hofmann TG, Stollberg N, Schmitz ML, Will H. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 2003; 63:8271-7; PMID:14678985
   PubMed Web of Science ®Google Scholar
• Gresko E, Roscic A, Ritterhoff S, Vichalkovski A, del Sal G, Schmitz ML. Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J 2006; 25:1883-94; PMID:16601678; http://dx.doi.org/10.1038/sj.emboj.7601077
   PubMed Web of Science ®Google Scholar
• MacLachlan TK, El-Deiry WS. Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc Natl Acad Sci U S A 2002; 99:9492-7; PMID:12089322; http://dx.doi.org/10.1073/pnas.132241599
   PubMed Web of Science ®Google Scholar
• de la Vega L, Grishina I, Moreno R, Kruger M, Braun T, Schmitz ML. A redox-regulated SUMOacetylation switch of HIPK2 controls the survival threshold to oxidative stress. Mol Cell 2012; 46:472-83; PMID:22503103; http://dx.doi.org/10.1016/j.molcel.2012.03.003
   PubMed Web of Science ®Google Scholar
• Schmitz ML, Rodriguez-Gil A, Hornung J. Integration of stress signals by homeodomain interacting protein kinases. Biol Chem 2014; 395:375-86; PMID:24225127
   PubMed Web of Science ®Google Scholar
• Zhivotovsky B, Kroemer G. Apoptosis and genomic instability. Nat Rev Mol Cell Biol 2004; 5:752-62; PMID:15340382; http://dx.doi.org/10.1038/nrm1443
   PubMed Web of Science ®Google Scholar
• Rinaldo C, Prodosmo A, Siepi F, Soddu S. HIPK2: a multitalented partner for transcription factors in DNA damage response and development. Biochem Cell Biol = Biochim Biol Cell 2007; 85:411-8; PMID:17713576; http://dx.doi.org/10.1139/O07-071
   PubMed Web of Science ®Google Scholar
• Kim YH, Sung KS, Lee SJ, Kim YO, Choi CY, Kim Y. Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1. FEBS Lett 2005; 579:6272-8; PMID:16253240; http://dx.doi.org/10.1016/j.febslet.2005.10.010
   PubMed Web of Science ®Google Scholar
• Hofmann TG, Jaffray E, Stollberg N, Hay RT, Will H. Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification. J Biol Chem 2005; 280:29224-32; PMID:15958389; http://dx.doi.org/10.1074/jbc.M503921200
   PubMed Web of Science ®Google Scholar